For the new study, researchers used a “secret-shopper” method to attempt to schedule an appointment for a patient weighing ...
Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the ...
Metsera released data from mid-stage trials on its lead obesity drug candidate, while a high stakes Medicare open enrollment approaches.
MET-097i’s mid-stage performance “bodes well” for Pfizer’s proposed buyout of Metsera, according to BMO Capital Markets, a ...
A large genome-wide analysis reports that common obesity traits share, and in some cases drive, risk for diabetic kidney ...
In the SIBAMATE study, more than 60% of patients lost at least 5% of body weight after 3 months of using ...
The study found that under permanent standard time, obesity would be reduced by 0.78% which equates to a reduction in 2.6 ...
Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing ...
According to the CDC, obesity affects 1 in 5 kids in the U.S. 906 Adventure Team Adventure Director Todd Poquette says one ...
Parent-focused behavioral interventions seem to be insufficient for preventing obesity at age 24 months, according to a review.
East Carroll Parish had the highest prevalence of obesity, while St. Tammany and Lafayette parishes had the lowest. How did ...
In a significant development, the Central Drugs Standard Control Organisation (CDSCO) has approved Novo Nordisk's Ozempic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results